{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T20:08:18Z","timestamp":1767125298809,"version":"3.37.3"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["NIID-1012"],"award-info":[{"award-number":["NIID-1012"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012319","name":"National Center for Global Health and Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ijid.2023.01.044","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T23:43:26Z","timestamp":1675899806000},"page":"70-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Comparison of population-based measles-rubella immunoglobulin G antibody prevalence between 2014 and 2019 in Lao People's Democratic Republic: Impacts of the national immunization program"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3215-0276","authenticated-orcid":false,"given":"Shinsuke","family":"Miyano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Vynnycky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chansay","family":"Pattamavone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6138-8235","authenticated-orcid":false,"given":"Yasunori","family":"Ichimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phonethipsavanh","family":"Nouanthong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kongxay","family":"Phounphenghack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chankham","family":"Tengbriacheu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bouaphne","family":"Khamphaphongphane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Franzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8229-0977","authenticated-orcid":false,"given":"Tae Un","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5804-6755","authenticated-orcid":false,"given":"Hendrikus","family":"Raaijimarkers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Komada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Funato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Hachiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2016","series-title":"The eighth national health sector development plan (NHSDP) 2016\u20132020","author":"Ministry of Health","key":"10.1016\/j.ijid.2023.01.044_bib0001"},{"year":"2020","series-title":"WHO\/UNICEF Estimates of national immunization coverage: Lao PDR","key":"10.1016\/j.ijid.2023.01.044_bib0002"},{"key":"10.1016\/j.ijid.2023.01.044_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194931","article-title":"Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine","volume":"13","author":"Hachiya","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2023.01.044_bib0004","doi-asserted-by":"crossref","first-page":"12545","DOI":"10.1038\/s41598-019-49018-y","article-title":"Estimating the immunogenicity of measles-rubella vaccination administered during a mass campaign in Lao People's Democratic Republic using multi-valent seroprevalence data","volume":"9","author":"Vynnycky","year":"2019","journal-title":"Sci Rep"},{"year":"2015","series-title":"Measles-Rubella Bulletin - Vol 09 Issue 12","key":"10.1016\/j.ijid.2023.01.044_bib0005"},{"year":"2019","series-title":"Measles-rubella Bulletin 2019","key":"10.1016\/j.ijid.2023.01.044_bib0006"},{"key":"10.1016\/j.ijid.2023.01.044_bib0007","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.4269\/ajtmh.20-1669","article-title":"Impact of a measles and rubella vaccination campaign on seroprevalence in southern Province, Zambia","volume":"104","author":"Carcelen","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijid.2023.01.044_bib0008","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/tmi.12737","article-title":"Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countries","volume":"21","author":"Cutts","year":"2016","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.ijid.2023.01.044_bib0009","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1080\/21645515.2021.1876486","article-title":"Seroprevalence against the measles virus after vaccination or natural infection in an adult population in Madinah, Saudi Arabia","volume":"17","author":"Mahallawi","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.ijid.2023.01.044_bib0010","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1016\/j.vaccine.2020.04.024","article-title":"Measles and rubella IgG seroprevalence in persons 6 month\u201335 years of age, Mongolia, 2016","volume":"38","author":"Nogareda","year":"2020","journal-title":"Vaccine"},{"year":"2018","series-title":"National strategy and plan of action for measles and rubella elimination 2018\u20132022","key":"10.1016\/j.ijid.2023.01.044_bib0011"},{"key":"10.1016\/j.ijid.2023.01.044_bib0012","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijid.2015.04.020","article-title":"Seroprevalence of chronic hepatitis B, as determined from dried blood spots, among children and their mothers in central Lao People's Democratic Republic: a multistage, stratified cluster sampling survey","volume":"36","author":"Komada","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2023.01.044_bib0013","doi-asserted-by":"crossref","first-page":"e88829","DOI":"10.1371\/journal.pone.0088829","article-title":"Chronic hepatitis B prevalence among children and mothers: results from a nationwide, population-based survey in Lao People's Democratic Republic","volume":"9","author":"Xeuatvongsa","year":"2014","journal-title":"PLoS One"},{"year":"2018","series-title":"Vaccination coverage cluster surveys: reference manual","key":"10.1016\/j.ijid.2023.01.044_bib0014"},{"year":"2013","series-title":"European region. Guidance on conducting serosurveys in support of measles and rubella elimination in the WHO European Region","key":"10.1016\/j.ijid.2023.01.044_bib0015"},{"key":"10.1016\/j.ijid.2023.01.044_bib0016","doi-asserted-by":"crossref","first-page":"S564","DOI":"10.1093\/infdis\/jir088","article-title":"Dried blood spots on filter paper as an alternative specimen for measles diagnostics: detection of measles immunoglobulin M antibody by a commercial enzyme immunoassay","volume":"204","author":"Uzicanin","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2023.01.044_bib0017","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/infdis\/162.5.1036","article-title":"Measles antibody: reevaluation of protective titers","volume":"162","author":"Chen","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2023.01.044_bib0018","first-page":"701","article-title":"Dried venous blood samples for the detection and quantification of measles IgG using a commercial enzyme immunoassay","volume":"81","author":"Riddell","year":"2003","journal-title":"Bull World Health Organ"},{"year":"2020","series-title":"Rubella vacccines: WHO position paper","key":"10.1016\/j.ijid.2023.01.044_bib0019"},{"key":"10.1016\/j.ijid.2023.01.044_bib0020","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0022-3476(82)80114-5","article-title":"Rubella immunity in older children, teenagers, and young adults: a comparison of immunity in those previously immunized with those unimmunized","volume":"101","author":"Robinson","year":"1982","journal-title":"J Pediatr"},{"key":"10.1016\/j.ijid.2023.01.044_bib0021","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/infdis\/148.4.639","article-title":"Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus","volume":"148","author":"O'Shea","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2023.01.044_bib0022","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/infdis\/149.3.459","article-title":"Latex-agglutination test for rubella antibody: validity of positive results assessed by response to immunization and comparison with other tests","volume":"149","author":"Storch","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2023.01.044_bib0023","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1001\/jama.1984.03340390028023","article-title":"Serological response to rubella revaccination","volume":"251","author":"Serdula","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2023.01.044_bib0024","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/sim.2291","article-title":"Modelling age-dependent force of infection from prevalence data using fractional polynomials","volume":"25","author":"Shkedy","year":"2006","journal-title":"Stat Med"},{"issue":"Suppl16","key":"10.1016\/j.ijid.2023.01.044_bib0025","doi-asserted-by":"crossref","first-page":"108","DOI":"10.29245\/2578-3009\/2018\/si.1116","article-title":"The impact of recent rubella vaccine introduction in 5 countries in the African region","author":"Luce","year":"2018","journal-title":"J Immunol Sci"},{"key":"10.1016\/j.ijid.2023.01.044_bib0026","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijid.2021.04.033","article-title":"Age-stratified seroprevalence of vaccine-preventable infectious disease in Saravan, Southern Lao People's Democratic Republic","volume":"107","author":"Xaydalasouk","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2023.01.044_bib0027","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ijid.2021.06.016","article-title":"Seroprevalence of measles and rubella antibodies in vaccinated and unvaccinated infants in the Lao People's Democratic Republic","volume":"108","author":"Hefele","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2023.01.044_bib0028","article-title":"Susceptibility to vaccine-preventable diseases in four districts of Xaysomboun Province, Lao People's Democratic Republic","volume":"10","author":"Virachith","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijid.2023.01.044_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10101316","article-title":"Waning of maternal antibodies against measles suggests a large window of susceptibility in infants in Lao People's Democratic Republic","volume":"10","author":"Khampanisong","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.ijid.2023.01.044_bib0030","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0140-6736(21)01337-4","article-title":"Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study","volume":"398","author":"Causey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2023.01.044_bib0031","unstructured":"World Health Organization. Provisional data based on monthly data, https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/immunization-analysis-and-insights\/surveillance\/monitoring\/provisional-monthly-measles-and-rubella-data; 2022 [accessed 25 December 2022]."},{"year":"2019","series-title":"Tailoring immunization programmes (TIP)","key":"10.1016\/j.ijid.2023.01.044_bib0032"},{"key":"10.1016\/j.ijid.2023.01.044_bib0033","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.vaccine.2021.11.067","article-title":"Improved childhood immunization coverage using the World Health Organization's Tailoring Immunization Programmes guide (TIP) in a regional centre in Australia","volume":"40","author":"Thomas","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2023.01.044_bib0034","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12961-021-00719-9","article-title":"Using participatory action research to improve immunization utilization in areas with pockets of unimmunized children in Nigeria","volume":"19","author":"Akwataghibe","year":"2021","journal-title":"Health Res Policy Syst"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971223000450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971223000450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T03:49:15Z","timestamp":1718250555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971223000450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":34,"alternative-id":["S1201971223000450"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2023.01.044","relation":{},"ISSN":["1201-9712"],"issn-type":[{"type":"print","value":"1201-9712"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of population-based measles-rubella immunoglobulin G antibody prevalence between 2014 and 2019 in Lao People's Democratic Republic: Impacts of the national immunization program","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2023.01.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}